Martin Flamant
Overview
Explore the profile of Martin Flamant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
1917
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Motiejunaite J, Alencar De Pinho N, Flamant M, Vidal-Petiot E
J Hypertens
. 2024 Aug;
42(10):1833-1834.
PMID: 39196696
No abstract available.
2.
Haviari S, de Tymowski C, Burnichon N, Lemogne C, Flamant M, Ruszniewski P, et al.
BMC Med Educ
. 2024 Jul;
24(1):817.
PMID: 39075511
Context: Objective Structured Clinical Examinations (OSCEs) are an increasingly popular evaluation modality for medical students. While the face-to-face interaction allows for more in-depth assessment, it may cause standardization problems. Methods...
3.
Delanaye P, Bjork J, Vidal-Petiot E, Flamant M, Ebert N, Schaeffner E, et al.
Nephrol Dial Transplant
. 2024 Jul;
40(3):516-523.
PMID: 39013610
Background: The estimation of glomerular filtration rate (GFR) is one tool to detect renal disease. The most used biomarker remains serum creatinine and the European Kidney Function Consortium (EKFCcrea) equation...
4.
Motiejunaite J, Flamant M, Arnoult F, Lahens A, Tabibzadeh N, Boutten A, et al.
Hypertens Res
. 2024 Jul;
47(9):2511-2520.
PMID: 38969804
Increasing attention has recently been paid to discrepancies between office and ambulatory blood pressure (BP) control in patients with chronic kidney disease (CKD), but information on mechanisms underlying circadian BP...
5.
Legrand F, Motiejunaite J, Arnoult F, Lahens A, Tabibzadeh N, Robert-Mercier T, et al.
J Hypertens
. 2024 Apr;
42(6):1000-1008.
PMID: 38647162
Objectives: Optimal blood pressure (BP) control is key to prevent cardiovascular complications in patients with chronic kidney disease (CKD). We described the prevalence and factors associated with masked hypertension in...
6.
Tazi A, Rabant M, Lemogne C, Flamant M, Cariou A, Baron S, et al.
Ann Biol Clin (Paris)
. 2024 Feb;
81(6):628-639.
PMID: 38391167
Pathology and biology are essential in the patient care. However, they suffer from a lack of attractiveness to medicine students. In order to gain insight and improve the visibility and...
7.
Michon-Colin A, Metzger M, Bankir L, Gauci C, Brunel M, Baron S, et al.
Clin Kidney J
. 2023 Dec;
16(12):2472-2481.
PMID: 38046034
Background: Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to...
8.
Delanaye P, Pottel H, Cavalier E, Flamant M, Stehle T, Mariat C
Nephrol Dial Transplant
. 2023 Nov;
39(7):1088-1096.
PMID: 37950562
Creatinine-based estimated glomerular filtration rate (eGFR) is imprecise at individual level, due to non-GFR-related serum creatinine determinants, including atypical muscle mass. Cystatin C has the advantage of being independent of...
9.
Nyman U, Bjork J, Delanaye P, Lahens A, Pottel H, Vidal-Petiot E, et al.
Clin Chem Lab Med
. 2023 Sep;
62(3):421-427.
PMID: 37768854
Objectives: To make glomerular filtration rate (GFR) estimating equations applicable across populations with different creatinine generation by using rescaled serum creatinine (sCr/Q) where sCr represents the individual creatinine level and...
10.
Stehle T, Ouamri Y, Morel A, Vidal-Petiot E, Fellahi S, Segaux L, et al.
Clin Kidney J
. 2023 Aug;
16(8):1265-1277.
PMID: 37529645
Background: Inter-individual variations of non-glomerular filtration rate (GFR) determinants of serum creatinine, such as muscle mass, account for the imperfect performance of estimated GFR (eGFR) equations. We aimed to develop...